Ayda Hussein Omer Mustafa

ORCID: 0000-0001-7310-9208
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Vitamin C and Antioxidants Research
  • BRCA gene mutations in cancer
  • Breast Cancer Treatment Studies
  • HER2/EGFR in Cancer Research
  • Edible Oils Quality and Analysis
  • Cholesterol and Lipid Metabolism
  • Cancer, Lipids, and Metabolism
  • Nutrition, Genetics, and Disease
  • Cancer Treatment and Pharmacology
  • Vitamin D Research Studies
  • Global Cancer Incidence and Screening

Al-Neelain University
2013-2025

<ns3:p>Background Breast cancer (BC) is a leading cause of cancer-related mortality among women worldwide. The role neoadjuvant chemotherapy (NAC) in improving clinical outcomes for breast patients has gained significant attention; however, its impact on long-term survival and recurrence rates remains under investigation. Thus, we evaluated the effectiveness NAC metastasis, rates, overall BC patients. Statistical analyses, including Chi-square tests Kaplan-Meier analysis, were employed to...

10.12688/f1000research.159563.1 preprint EN cc-by F1000Research 2025-01-09

Vitamin D deficiency is a worldwide concern. The aim of the current study was to determine vitamin level and its contributing factors in Sudanese women.In this cross-sectional study, 251 women attending Family Health Centers Khartoum, Sudan were interviewed. Following exclusion confounding factors, samples from 190 analzsed. Serum 25 hydroxyvitamin "25(OH) D" quantified using competitive electrochemiluminescence immunoassay.Participants' age ranged 18 85 years with mean (±SD) 40.2 (±14.06)...

10.4103/jfmpc.jfmpc_247_19 article EN cc-by-nc-sa Journal of Family Medicine and Primary Care 2019-01-01

Introduction: Prognosis of breast cancer depends mainly on early detection the disease it is also well known stage at diagnosis inversely associated with five-year survival rate nodal involvement main prognostic factor. Other factors are prognosis like molecular subtype tumor, socioeconomic status patient, and modalities treatment received. The management patient going to be planned according diagnosis, aggressiveness disease; course, timing investigation influenced by patient. We have...

10.33425/2639-8478.1078 article EN Cancer Science & Research 2021-12-30
Coming Soon ...